About
Representation
View all Representation →Consultations- Digitisation Taskforce – Final Report
- FCA Consults on Fund Product Information and Cost Disclosure CP24/30 – ShareSoc Responds
- FRC Consults on UK Stewardship Code – ShareSoc Responds
- FCA Consultation – Modernising Redress
- HMRC Consultation – IHT on Pensions
- ShareSoc Evidence to Lords on FCA Enforcement
- ShareSoc supports FCA proposal for criminal background checks on owners and controllers of financial institutions
- UK ISA: ShareSoc submits consultation response
- FCA Consultation on Enforcement Practice & Transparency
- ShareSoc response to House of Commons Education Select Committee
- UKSA and ShareSoc Submission to Labour Party Review of Financial Services
- FCA Consultation GC23/2 Financial Promotions on Social Media
- VIEW ALL CONSULTATIONS
Education
Events
View all Events →Upcoming Events- Oct19SIGnet York Group Launch Meeting
- Oct21ShareSoc Webinar with The European Smaller Companies Trust (ESCT)
- Oct27Asset Match webinar on PISCES: what it means for liquidity in private company shares
- Oct27SIGnet North Leeds / Harrogate / Skipton Group Launch Meeting
- Forums
Company
GLAXOSMITHKLINE PLC (GSK)
Blog posts
Good Articles in Investors’ Chronicle
Post Date: October 20, 2021
The views expressed in this article are those of the author and not necessarily those of ShareSoc
There were several good articles in this week’s Investors’ Chronicle. I cover them briefly below.
The Editor, Rosie Carr, reported on feedback on readers’ views on taxation. Should the wealthy readers of the IC pay more was one question previously posed and the consensus answer seemed to be Yes. For pensioners it was suggested that they should pay National Insurance on their income and that there ...
Market Trends, Interest Rates, Glaxo and Yu Group Accounts
Post Date: December 20, 2018
Yesterday was another dismal day in the markets. The US fell significantly allegedly caused by the rise in interest rates announced by the Federal Reserve and the UK market followed it down this morning. The US rate rise was widely expected although perhaps slightly lower estimates for US economic growth had an impact. But when the markets are in a bear mood, excuses for selling abound. Meanwhile the Bank of England has announced today that their base rate will remain at ...
Who are the Election Winners and Losers?
Post Date: May 8, 2015
Who are the General Election winners and losers? Well most investors have benefited because the market as a whole has risen today after the election results gave the Conservatives an unexpected victory. Specific sectors that benefited were house builders and utility companies. House builders were generally up at the time of writing this note, with Berkeley Group in particular up 10% - no doubt investors being relieved there would be no mansion tax affecting expensive properties in London. Utility companies were ...
2014 Review and New Year Resolutions
Post Date: January 3, 2015
Now's the time of year to look back on the performance of the stock market in 2014, and look at plans for the future. Last year was undoubtedly a disappointing year for the UK stock market. The FTSE All-Share index was down 2.45%, worse than many other major markets. The cause was undoubtedly that the All-Share index is dominated by large mega-cap FTSE-100 companies such as BP, Shell, Glaxo and Tesco. The first two have been badly hit by the decline ...
Glaxo Q3 results – in need of more treatment
Post Date: October 22, 2014
GlaxoSmithKline (GSK) issued its 3rd Quarter Results today (22 Oct 2014). It's one of those large FTSE-100 stocks that it's difficult to avoid holding if you are a UK stock market investor. It's such a large constituent of the index that all those index funds, and indeed almost all generalist unit or investment trusts, are likely to have a big stake in them. It's also one of those stocks that many people hold directly (as does this writer) simply as a ...
High pound also impacts Renishaw and GlaxoSmithKline
Post Date: July 24, 2014
Following on from my blog post a couple of days ago about the high pound impacting the profits of technology companies, yesterday saw final results from Renishaw (RSW) and interims from GlaxoSmithKline (GSK) which reflected the same issue. However, the currency impact in both companies was not the main impact on the subsequent share price move.
At Renishaw, profits would have been £6.8m higher on top of an "adjusted" figure of £70.1m for the year, but for the currency impact. Last years ...
AGM Reports
GlaxoSmithKline (GSK) AGM 2016
Post Date: May 9, 2016
As usual it was an afternoon meeting at 2:30 pm in the Queen Elizabeth II Conference Centre, with one of the biggest audiences I have ever seen there. All the overflow areas were also full. This is one of our biggest companies, with a turnover this year of £23.9bn (£223.0bn) and a total profit declared at £10.3bn (£3.6bn).
Sir Phillip Hampton, the new Chairman, appointed 1st January this year, opened the meeting on time. He started positively, emphasising the tremendous reorganisation which ...
GlaxoSmithKline Plc (GSK) AGM 2015
Post Date: May 9, 2015
The following report is shorter than usual due to the AGM containing very little of substance, highlighting the difficulty a large FTSE company has in running such an event.
On Thursday the 7th of May I attended the Annual General Meeting of GlaxoSmithKline Plc at the QEII Conference Centre, London at 2.30pm. The meeting was attended by about 600 shareholders, less than last year, probably due to the general election being on the same day. On my entry to the building I ...
GlaxoSmithKline Plc (GSK) AGM Report 2014
Post Date: May 9, 2014
On Wednesday the 7th of May I attended the Annual General Meeting of GlaxoSmithKline Plc at the QEII Conference Centre, London at 2.30pm. The meeting was well attended with well over 1000 shareholders present, more than GSK originally anticipated as more chairs were called for as the room quickly filled up. Results were in line with expectations at £26.5bn turnover and £8bn core operating profit.
After quickly perusing the 251 page report (then putting it on the floor, due the weight of ...
GlaxoSmithKline (GSK) AGM 2013 – a subdued affair
Post Date: May 2, 2013
It was an afternoon meeting, at 2:30 pm in the Queen Elizabeth 11 Conference Centre, with a somewhat smaller audience than I have seen in earlier years. This is one of our biggest companies, with a turnover this year of £26.4bn (£27.4bn) and a total profit declared at £7.4bn (£7.8bn). We note with some approval that executive director’s remuneration was down from £11.4m to £8m to £16.2m and total directors’ remuneration from £16.2m to £10.7m, and the latter two figures each ...
Corporate Remuneration Reports
GlaxoSmithKline Remuneration Report 2016
Post Date: May 2, 2016
Attached is the Manifest Report. Manifest Executive Remuneration Assessment grade 'D’ (on scale A =good to F=awful) Manifest has assessed the Company’s disclosures against the recommendations of the UK Corporate Governance Code, institutional investor guidelines and the disclosure requirements set out in both the Companies Acts and the UKLA Listing Rules. The following items have been identified which may be of interest to shareholders:
Remuneration policy fails to establish a strong degree of alignment between executive remuneration and KPIs/Company strategy.
Total ...
Become a free Associate ShareSoc member
Enter your email to sign up as a free Associate ShareSoc member and receive our emails. It takes a few seconds — and on the next page you'll have the option to customise your membership.